Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.73 USD | +5.51% | +3.99% | -7.23% |
Apr. 19 | Xenon Pharmaceuticals Inc. Announces Board Resignations | CI |
Mar. 11 | Transcript : Xenon Pharmaceuticals Inc. Presents at Leerink Partners Global Biopharma Conference 2024, Mar-11-2024 11:20 AM |
Financials (USD)
Sales 2024 * | 2.39M | Sales 2025 * | 9.5M | Capitalization | 3.06B |
---|---|---|---|---|---|
Net income 2024 * | -220M | Net income 2025 * | -260M | EV / Sales 2024 * | 1,043 x |
Net cash position 2024 * | 560M | Net cash position 2025 * | 507M | EV / Sales 2025 * | 268 x |
P/E ratio 2024 * |
-13.7
x | P/E ratio 2025 * |
-12.2
x | Employees | 255 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.16% |
Latest transcript on Xenon Pharmaceuticals Inc.
1 day | +5.51% | ||
1 week | +3.99% | ||
Current month | -0.74% | ||
1 month | +1.40% | ||
3 months | -6.44% | ||
6 months | +35.65% | ||
Current year | -7.23% |
Managers | Title | Age | Since |
---|---|---|---|
Ian Mortimer
CEO | Chief Executive Officer | 48 | 13-10-20 |
Simon Pimstone
FOU | Founder | 56 | 96-11-04 |
Sherry Aulin
DFI | Director of Finance/CFO | 40 | 10-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Clarence Machado
BRD | Director/Board Member | 60 | 20-11-04 |
Mohammad Azab
BRD | Director/Board Member | 68 | 03-09-30 |
Justin Gover
BRD | Director/Board Member | 53 | 23-08-07 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.96% | 16 M€ | -7.06% | ||
0.22% | 0 M€ | 0.00% | - | |
0.22% | 0 M€ | 0.00% | - | |
0.20% | 12 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 40.5 | +1.00% | 320,772 |
24-04-25 | 40.1 | +1.52% | 255,970 |
24-04-24 | 39.5 | -3.87% | 325,554 |
24-04-23 | 41.09 | +2.70% | 323,512 |
Delayed Quote Nasdaq, April 29, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.23% | 3.06B | |
-2.63% | 103B | |
+1.62% | 95.28B | |
+1.46% | 22.15B | |
-16.67% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.21% | 16.05B | |
+5.41% | 13.68B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- XENE Stock